Barclays sets Exact Sciences stock price target at $70 with Overweight rating
Barclays (LON:BARC) initiated coverage on Exact Sciences (NASDAQ:EXAS), a leading molecular diagnostics company with a market capitalization of $10.14 billion, assigning the stock an Overweight rating ...
A toothbrush that detects cavities. A test that picks up cancer BEFORE symptoms strike. And ...
The vial in my hand contains just one millilitre of blood - barely enough to fill a thimble. But by tomorrow it could reveal whether I have one of the six most deadly cancers.